hyperopia,
Great post and thanks for the effort. Now add to this that initial UK demand will likely be over 300 patients per month with nGBM, rGBM and foreign self pay so the PIM funding of $350,000,000 looks to last no more than about 6 months max which is December if some production is outsourced to meet expected demand as Sawston only appears to be ready for about 100 patients per month right now. The Q3 manual production ramp should be very significant and the Cambridge news about it should be strong and like you, I expect late Q3 or Q4 implementation of Eden for full commercializtion readiness with expansion model in place and MHRA approval between now and then. The journal article and TLD just lets NWBO talk a little about plans that have already been telegraphed to longs that are paying attention. Thanks again. Best wishes.